NNH: Q1 2026 saw a 7.9% sales decline and a net loss, but growth in the Nordics and Rest of World

About this update from New Nordic Healthbrands Ab

Net sales declined 7.9% year-over-year in Q1 2026, with losses driven by weaker sales in North America and the UK, while the Nordic region and Rest of World saw growth. Gross margin fell to 62.4%, and the company expects improvement in Q2.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for New Nordic Healthbrands Ab